BioSpace News Archive

According to the report, the global vascular closure devices market was valued at US$ 0.8 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

Vifor Pharma Group announced that Colin Bond, Chief Financial Officer will retire from the company by the end of December 2021 at his own request.

American CryoStem Corporation, a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies announced completion of its Phase I clinical protocol design for the treatment of Long COVID.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, announced a series of executive changes.

Immunovia AB announced that the Company’s President and Chief Executive Officer, Patrik Dahlen, has informed the Board of Directors of his intention to step down, for personal reasons.

A three-year study of more than 1,000 patients found that the risk of delayed intracranial hemorrhage and death following head trauma was significantly higher for adults taking older blood thinning medications including clopidogrel and warfarin, according to research being presented at the annual meeting of the Radiological Society of North America.

Confo Therapeutics announced that it has entered into a collaborative agreement with Regeneron Pharmaceuticals, Inc. whereby Confo’s technology platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs in disease-relevant conformations, will be applied with the goal of enabling the discovery of novel therapeutic antibody drug candidates.

Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, announced the establishment of a new Scientific and Technical Advisory Board to support Vizgen’s vision to bring the most advanced spatial-omics tools to the life science research community.

Pompe disease is a genetic mutation that generally occurs in infants. In this condition, the body is unable to produce a specific enzyme that is responsible for breaking glycogen into a simple sugar.

Fact.MR – A Market Research and Competitive Intelligence Provider: Microplate Absorbance Reader Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.